Literature DB >> 31857691

Correcting the ASCO position on phase I clinical trials in cancer.

Howard A Burris1,2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 31857691     DOI： 10.1038/s41571-019-0311-4

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  6 in total

1.  Reply to 'Correcting the ASCO position on phase I clinical trials in cancer'.

Authors:  Jonathan Kimmelman
Journal:  Nat Rev Clin Oncol       Date:  2020-02       Impact factor: 66.675

2.  Early drug development in solid tumours: analysis of National Cancer Institute-sponsored phase 1 trials.

Authors:  Dai Chihara; Ruitao Lin; Christopher R Flowers; Shanda R Finnigan; Lisa M Cordes; Yoko Fukuda; Erich P Huang; Larry V Rubinstein; Loretta J Nastoupil; S Percy Ivy; James H Doroshow; Naoko Takebe
Journal:  Lancet       Date:  2022-08-13       Impact factor: 202.731

3.  Trends in Grade 5 Toxicity and Response in Phase I Trials in Hematologic Malignancy: 20-Year Experience From the Cancer Therapy Evaluation Program at the National Cancer Institute.

Authors:  Dai Chihara; Erich P Huang; Shanda R Finnigan; Lisa M Cordes; Nebojsa Skorupan; Yoko Fukuda; Larry V Rubinstein; S Percy Ivy; James H Doroshow; Loretta J Nastoupil; Christopher R Flowers; Naoko Takebe
Journal:  J Clin Oncol       Date:  2022-03-09       Impact factor: 50.717

4.  Pattern of Treatment Initiation and Outcomes for Patients With Metastatic Non-small Cell Lung Cancer in Ontario.

Authors:  Jerry W Ding; Abdulkadir A Hussein; Zhong Ren Huang; Kamran Ehsan; Devinder Moudgil; Swati Kulkarni
Journal:  Cureus       Date:  2022-04-29

5.  Validation of prognostic scoring systems for patients with metastatic renal cell carcinoma enrolled in phase I clinical trials.

Authors:  Andrew W Hahn; Omar Alhalabi; Pavlos Msaouel; Funda Meric-Bernstam; Aung Naing; Eric Jonasch; Sarina Piha-Paul; David Hong; Shubham Pant; Timothy Yap; Erick Campbell; Hung Le; Nizar M Tannir; Jason Roszik; Vivek Subbiah
Journal:  ESMO Open       Date:  2020-11

6.  Decision-making about clinical trial options among older patients with metastatic cancer who have exhausted standard therapies.

Authors:  Mazie Tsang; Rebecca J DeBoer; Sarah B Garrett; Daniel Dohan
Journal:  J Geriatr Oncol       Date:  2022-02-04       Impact factor: 3.929
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.